{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:07:42Z","timestamp":1794406062615,"version":"4.9.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Ulcerative colitis (UC) is a chronic inflammatory bowel disease marked by immune cell infiltration, crypt erosion, and severe ulceration. In phase 3 studies with etrolizumab, the results of a transcriptional analysis of colonic biopsies revealed that etrolizumab-mediated integrin \u03b27 blockade, but not adalimumab (a TNF-blocking antibody), reduced genes associated with integrin \u03b1E\u03b27+ intraepithelial lymphocytes (IELs). Both treatments significantly reduced stromal and myeloid cell-related genes linked to Mayo Clinic Score (MCS) remission status. A single-cell atlas from UC biopsies identified 36 distinct cell populations, including myeloid cells. This atlas enabled cell-specific signatures and cellular deconvolution of the phase 3 data, showing reductions in neutrophils, monocyte-derived macrophages, and inflammatory fibroblasts, along with increases in epithelial cells common to both treatments. Pseudo-time analyses identified four neutrophil subsets, transitioning from PADI4hi, OSMhi, and MX1hi to CXCR4hi populations. PADI4hi and OSMhi neutrophils exhibited high protease, cytokine (CXCL1, IL1B, OSM), and chemokine receptor (CXCR1, CXCR2) levels, while MX1hi expressed markers of IFN exposure. CXCR4hi neutrophils showed elevated CXCL2, TNF, and VEGFA levels. Notably, interactions between PADI4hi and OSMhi neutrophils and inflammatory fibroblasts, such as OSM and IL1B, were associated with MCS remission with both drugs. CXCR4hi neutrophils showed only minor changes unrelated to clinical outcomes. These findings suggest that neutrophils are highly heterogeneous, with abundant interactions in inflamed colonic tissue, potentially perpetuating chronic disease. Disrupting neutrophil interactions with myeloid and resident cells like inflammatory fibroblasts could reduce inflammation, possibly enhancing clinical remission rates.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1705328","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:45:21Z","timestamp":1781160321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A single-cell atlas of ulcerative colitis reveals neutrophil\u2013stromal circuits linked to biologic therapy resistance"],"prefix":"10.3389","volume":"17","author":[{"given":"Shadi Toghi","family":"Eshghi","sequence":"first","affiliation":[{"name":"Computational Sciences, Research and Early Development, Genentech Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Mark","family":"Gubatan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Mazrooei","sequence":"additional","affiliation":[{"name":"Computational Sciences, Research and Early Development, Genentech Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Quintanilla","sequence":"additional","affiliation":[{"name":"Computational Sciences, Research and Early Development, Genentech Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Translational Medicine, Research and Early Development, Genentech Inc","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Au-Yeung","sequence":"additional","affiliation":[{"name":"Translational Medicine, Research and Early Development, Genentech Inc","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek R.","family":"Holman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Translational Medicine, Research and Early Development, Genentech Inc","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Product Development, Data Sciences, Genentech Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"O\u2019Gorman","sequence":"additional","affiliation":[{"name":"Translational Medicine, Research and Early Development, Genentech Inc","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Keir","sequence":"additional","affiliation":[{"name":"Immunology Discovery, Research and Early Development, Genentech Inc","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroja","family":"Ramanujan","sequence":"additional","affiliation":[{"name":"Preclinical & Translational Pharmacokinetics and Pharmacodynamics (PKPD), Genentech Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rogalla","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Hackney","sequence":"additional","affiliation":[{"name":"Computational Sciences, Research and Early Development, Genentech Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"McBride","sequence":"additional","affiliation":[{"name":"Translational Medicine, Research and Early Development, Genentech Inc","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0000000000000763","article-title":"Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease","volume":"22","author":"Click","year":"2016","journal-title":"Inflammation Bowel Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gou087","article-title":"Optimizing the use of biological therapy in patients with inflammatory bowel disease","volume":"3","author":"Moss","year":"2015","journal-title":"Gastroenterol Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)60661-9","article-title":"Etrolizumab as induction therapy for ulcerative colitis: A randomised, controlled, phase 2 trial","volume":"384","author":"Vermeire","year":"2014","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100381","article-title":"Dual targeting of lymphocyte homing and retention through \u03b14\u03b27 and \u03b1E\u03b27 inhibition in inflammatory bowel disease","volume":"2","author":"Dai","year":"2021","journal-title":"Cell Rep Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100220","article-title":"Regulation and role of \u03b1E integrin and gut homing integrins in migration and retention of intestinal lymphocytes during inflammatory bowel disease","volume":"207","author":"Keir","year":"2021","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s2468-1253(21)00338-1","article-title":"Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials","volume":"7","author":"Rubin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.178665","article-title":"Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis","volume":"58","author":"Arijs","year":"2009","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321731","article-title":"Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance","volume":"70","author":"Aschenbrenner","year":"2021","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal\u2013neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07841-3","article-title":"Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response","volume":"10","author":"Haberman","year":"2019","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.02.542863","article-title":"Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis","author":"Jha","year":"2023","journal-title":"bioRxiv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2018","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor\u2013neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","article-title":"Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease","volume":"14","author":"Garrido-Trigo","year":"2023","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9010","DOI":"10.1038\/s41598-021-88489-w","article-title":"Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy","volume":"11","author":"Penrose","year":"2021","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac246","article-title":"The clinical response of upadacitinib and risankizumab is associated with reduced inflammatory bowel disease anti-TNF-\u03b1 Inadequate response mechanisms","volume":"29","author":"Wang","year":"2022","journal-title":"Inflammation Bowel Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci41649","article-title":"CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow","volume":"120","author":"Eash","year":"2010","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00629.x","article-title":"Human neutrophil granules and secretory vesicles","volume":"51","author":"Borregaard","year":"1993","journal-title":"Eur J Haematol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.66.6.989","article-title":"The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules","volume":"66","author":"Cowland","year":"1999","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.immuni.2019.02.006","article-title":"Anti-commensal igG drives intestinal inflammation and type 17 immunity in ulcerative colitis","volume":"50","author":"Castro-Dopico","year":"2019","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0b013e31829ed7df","article-title":"Keeping the bowel regular","volume":"19","author":"Gibson","year":"2013","journal-title":"Inflammation Bowel Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40495-017-0105-2","article-title":"Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease","volume":"3","author":"Hu","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020400","article-title":"The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis","volume":"11","author":"Ka\u0142u\u017cna","year":"2022","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01680-y","article-title":"Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity","volume":"28","author":"Uzzan","year":"2022","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/gutjnl-2017-315494","article-title":"Cell-centred meta-analysis reveals baseline predictors of anti-TNF\u03b1 non-response in biopsy and blood of patients with IBD","volume":"68","author":"Gaujoux","year":"2019","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","article-title":"Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways","volume":"179","author":"Huang","year":"2019","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2015.10.041","article-title":"Association between response to etrolizumab and expression of integrin \u03b1E and granzyme A in colon biopsies of patients with ulcerative colitis","volume":"150","author":"Tew","year":"2016","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3021863","article-title":"Anti-TNF-\u03b1 Therapy suppresses proinflammatory activities of mucosal neutrophils in inflammatory bowel disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41575-019-0211-1","article-title":"Evolving therapeutic goals in ulcerative colitis: towards disease clearance","volume":"17","author":"Danese","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000183","article-title":"A treat-to-target update in ulcerative colitis: A systematic review","volume":"114","author":"Ungaro","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","article-title":"A neutrophil timer coordinates immune defense and vascular protection","volume":"50","author":"Adrover","year":"2019","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21106","article-title":"CXCL12 Is a constitutive and inflammatory chemokine in the intestinal immune system","volume":"16","author":"Dotan","year":"2010","journal-title":"Inflammation Bowel Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122574","article-title":"CXCR4 promotes B cell egress from Peyer\u2019s patches","volume":"210","author":"Schmidt","year":"2013","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0111101","article-title":"Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease","volume":"90","author":"Werner","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1038\/s41467-019-10769-x","article-title":"Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification","volume":"10","author":"Czarnewski","year":"2019","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0408231","article-title":"The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice","volume":"84","author":"Bento","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.145862","article-title":"Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis","volume":"329","author":"Farooq","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"B46","article-title":"Blockade of CXCR2 suppresses proinflammatory activities of neutrophils in ulcerative colitis","volume":"12","author":"Zhu","year":"2020","journal-title":"Am J Transl Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci98642","article-title":"Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn\u2019s disease","volume":"128","author":"Mao","year":"2018","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972114","article-title":"Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease","volume":"13","author":"Shaul","year":"2022","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03309-5","article-title":"Therapeutic inhibition of CXCR1\/2: where do we stand","volume":"18","author":"Sitaru","year":"2023","journal-title":"Intern Emerg Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18129\/B9.bioc.HTSeqGenie","article-title":"HTSeqGenie: A NGS analysis pipeline","author":"Pau","year":"2023"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq057","article-title":"Fast and SNP-tolerant detection of complex variants and splicing in short reads","volume":"26","author":"Wu","year":"2010","journal-title":"Bioinformatics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2018.1447542","article-title":"Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk","volume":"53","author":"Smillie","year":"2018","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1101\/2023.07.18.549537","article-title":"Scalable querying of human cell atlases via a foundational model reveals commonalities across fibrosis-associated macrophages","volume":"638","author":"Heimberg","year":"2024","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1705328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:45:25Z","timestamp":1781160325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1705328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2026.1705328"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s008","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s009","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s010","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s011","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s012","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s013","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s014","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s015","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s016","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s017","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705328.s018","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1705328"}}